Status:
UNKNOWN
COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
SARS-CoV-2 Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current pandemic caused by the newly identified coronavirus responsible for COVID-19 is a major threat to our populations and societies. Hypothesis/Objective The acquisition of protective immunit...
Eligibility Criteria
Inclusion
- Patients who have recovered from CoV-2-SARS
- Adult patient (≥ 18 years old) with a positive SARS-CoV-2 PCR.
- Adult patient (≥ 18 years old) who has recovered from SARS-CoV-2 i.e. has been free of clinical symptoms for more than 15 days and has not been hospitalized and for less than 6 weeks.
- Patient affiliated to a social security scheme.
- Patients hospitalized for SARS-CoV-2
- Adult patient (≥ 18 years old) with a positive SARS-CoV-2 PCR.
- Adult patient (≥ 18 years old) with clinical symptoms for more than 3 days and hospitalized.
Exclusion
- Refusal of the patient to participate in the study.
- Patient under guardianship / curatorship
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04402892
Start Date
June 1 2020
End Date
March 1 2021
Last Update
May 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.